BACKGROUND AND PURPOSE: Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use. METHODS: The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test. RESULTS: The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4). CONCLUSIONS: Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted. CLINICAL TRIAL REGISTRATION URL: http://clinicaltrials.gov. Unique identifier: NCT00930280.
BACKGROUND AND PURPOSE:Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use. METHODS: The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test. RESULTS: The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4). CONCLUSIONS: Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted. CLINICAL TRIAL REGISTRATION URL: http://clinicaltrials.gov. Unique identifier: NCT00930280.
Authors: Daniel Woo; Brett M Kissela; Jane C Khoury; Laura R Sauerbeck; Mary A Haverbusch; Jerzy P Szaflarski; James M Gebel; Arthur M Pancioli; Edward C Jauch; Alexander Schneider; Dawn Kleindorfer; Joseph P Broderick Journal: Stroke Date: 2004-04-15 Impact factor: 7.914
Authors: Brett Kissela; Alexander Schneider; Dawn Kleindorfer; Jane Khoury; Rosemary Miller; Kathleen Alwell; Daniel Woo; Jerzy Szaflarski; James Gebel; Charles Moomaw; Arthur Pancioli; Edward Jauch; Rakesh Shukla; Joseph Broderick Journal: Stroke Date: 2004-02 Impact factor: 7.914
Authors: Miriam R Raffeld; Alessandro Biffi; Thomas W K Battey; Alison M Ayres; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand; Christopher D Anderson Journal: Neurology Date: 2015-06-26 Impact factor: 9.910
Authors: Isabel Charlotte Hostettler; David Seiffge; Andrew Wong; Gareth Ambler; Duncan Wilson; Clare Shakeshaft; Gargi Banerjee; Nikhil Sharma; Hans Rolf Jäger; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Y H Lip; Martin M Brown; Keith Muir; Henry Houlden; David J Werring Journal: Neurology Date: 2022-07-08 Impact factor: 11.800
Authors: Duangnapa Roongpiboonsopit; Andreas Charidimou; Christopher M William; Arne Lauer; Guido J Falcone; Sergi Martinez-Ramirez; Alessandro Biffi; Alison Ayres; Anastasia Vashkevich; Oluwole O Awosika; Jonathan Rosand; M Edip Gurol; Scott B Silverman; Steven M Greenberg; Anand Viswanathan Journal: Neurology Date: 2016-09-30 Impact factor: 9.910